At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
Nicotine patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
In Brief
A clinical study evaluating Nicotine patch and Placebo patch for Nicotine Dependence. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The primary objective of this study is to determine whether the application of transdermal nicotine patches in critically ill patients after major surgery with nicotine abstinence condition is associated with a lower incidence of delirium.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesCzechia
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedFeb 2019
Primary CompletionJan 2021
Study CompletionFeb 2021
TodayJul 2026
First PostedFeb 20, 2019
Enrollment StartSep 23, 2015
Primary CompletionJan 31, 2021
Study CompletionFeb 8, 2021
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 7.4 years ago
Interventions
Nicotine patchdrug
The patients will receive a nicotine patch for the period of a maximum of 7 days.
Placebo patchother
The patients will receive a placebo patch for the period of a maximum of 7 days.